Home
Membership
Join ACRO
Current Members
Initiatives
COVID-19
Decentralized Trials
Clinical Research Roundtables
CRO Forum
Risk-Based Quality Management
Advocacy
US Legislation & Regulation
EU Legislation & Regulation
Global Data Protection & Privacy
Addressing Industry Pain Points
CFO Roundtable
About
Facts & Figures on Clinical Research
Our Mission
News
Subscribe
Leadership
Contact Us
Clinical Trial Resources for Patients
CRO Forum
Food and Drug Administration Guidance: Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency
April 21, 2020
By
Beekeeper Team
Previous Article
PPD Press Release: Accelerated Enrollment Solutions Launches Patient-Transfer Program to Support Clinical Trial Continuity for Biopharma Companies During COVID-19 Pandemic
Next Article
Syneos Health White Paper: Accelerate Rare Disease Drug Development in Light of COVID-19 and Other Challenges